secwatch / observer
8-K filed February 8, 2023, 6:59 PM ET ticker TWST CIK 0001581280
other material confidence high sentiment neutral materiality 0.10

Twist Bio annual meeting elects directors, approves say-on-pay, ratifies auditor

Twist Bioscience Corp

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Twist Bioscience Corp shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-02-07 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-02-07
Exact text from the filing
Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered accounting firm for the fiscal year ending September 30, 2023 by the following votes: Votes For Votes Against Abstentions 52,003,570 17,623 47,382
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Twist Bioscience Corp shareholders approved Election of Directors at the 2023-02-07 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-02-07
Exact text from the filing
Proposal One — Election of Directors The Company’s stockholders approved the election of two directors to the Company’s Board of Directors (“Board”) as Class II Directors by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Keith Crandell 33,891,453 13,264,841 4,912,281 Jan Johannessen 32,240,144 14,916,150 4,912,281
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Twist Bioscience Corp shareholders approved Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2023-02-07 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-02-07
Exact text from the filing
Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers (“NEOs”) The Company’s stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company’s NEOs by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 43,379,295 3,746,996 30,003 4,912,281
View on SEC.gov

Browse all shareholder votes →

Twist Bioscience Corp filing history →

Source: SEC EDGAR
accession 0001104659-23-014513
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.